CurveBeam AI (ASX:CVB) Change In Receivables : A$0.00 Mil (TTM As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is CurveBeam AI Change In Receivables?

CurveBeam AI's change in receivables for the quarter that ended in Dec. 2023 was A$0.00 Mil. It means CurveBeam AI's Accounts Receivable stayed the same from Jun. 2023 to Dec. 2023 .

CurveBeam AI's change in receivables for the fiscal year that ended in Jun. 2023 was A$0.00 Mil. It means CurveBeam AI's Accounts Receivable stayed the same from Jun. 2022 to Jun. 2023 .

CurveBeam AI's Accounts Receivable for the quarter that ended in Dec. 2023 was A$3.47 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. CurveBeam AI's Days Sales Outstanding for the six months ended in Dec. 2023 was 185.01.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. CurveBeam AI's liquidation value for the six months ended in Dec. 2023 was A$-1.67 Mil.

CurveBeam AI Change In Receivables Historical Data

The historical data trend for CurveBeam AI's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CurveBeam AI Change In Receivables Chart

CurveBeam AI Annual Data

Trend

Jun21

Jun22

Jun23

Change In Receivables

CurveBeam AI Semi-Annual Data
	Jun21	Dec21	Jun22	Jun23	Dec23
Change In Receivables	-	-	-	-	-

CurveBeam AI Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.00 Mil.

CurveBeam AI (ASX:CVB) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

CurveBeam AI's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	3.465	/	3.418	*	91
=	185.01

2. In Ben Graham's calculation of liquidation value, CurveBeam AI's accounts receivable are only considered to be worth 75% of book value:

CurveBeam AI's liquidation value for the quarter that ended in Dec. 2023 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	14.958	-	23.843	+	0.75 * 3.465	+	0.5 * 9.238
=	-1.67

CurveBeam AI Change In Receivables Related Terms

Thank you for viewing the detailed overview of CurveBeam AI's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

CurveBeam AI (ASX:CVB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CurveBeam AI Ltd (ASX:CVB) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

10?16 Queen Street, Level 10, Melbourne, VIC, AUS, 3000

Website

https://www.curvebeamai.com

CurveBeam AI Ltd is a manufacturer of specialized imaging equipment that has developed software that, through the use of artificial intelligence (AI), and deep learning AI (DLAI), automates the scan processing and analysis of the high-quality images produced from the Company's CT devices to assist in the clinical assessment and management of musculoskeletal health conditions, with a focus on orthopedic and bone health issues. The Company is the first to market with natural bilateral weight-bearing and non-weight-bearing CT, point-of-care imaging equipment with targeted proprietary AI solutions.

CurveBeam AI (ASX:CVB) Headlines

No Headlines